Eyepoint Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$696
$620
$966
$5,333
Gross Profit
168
245
245
5,168
EBITDA
-87,226
-70,345
-59,156
-61,689
EBIT
-59,732
-62,227
Net Income
-84,832
-67,609
-59,732
-59,426
Net Change In Cash
696
620
966
5,333
Free Cash Flow
-81,546
-66,033
-60,152
-63,809
Cash
77,712
101,821
74,577
71,143
Basic Shares
85,999
83,031
70,168
69,926

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$31,371
$43,273
$46,018
$41,404
Gross Profit
29,305
39,561
41,386
33,078
EBITDA
-243,434
-129,226
-69,001
-96,619
EBIT
-130,766
-69,465
-99,065
Net Income
-231,962
-130,870
-70,795
-102,254
Net Change In Cash
31,371
43,273
46,018
41,404
Cost of Revenue
-82,960
Free Cash Flow
-243,390
-130,278
-1,608
-67,155
Cash
101,821
99,704
281,263
95,633
Basic Shares
73,251
56,298
38,904
37,317

Earnings Calls

QuarterEPS
2026-03-31
-$0.99
2025-12-31
-$0.81
2025-09-30
-$0.85
2025-06-30
-$0.85